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2Abstract
      Increasing amounts of data available from influenza virus genome sequencing projects
have necessitated the need for centralized repositories for the collection, integration, and
dissemination of these data to researchers for further research. The RIT Influenza Virus
Database, a complete genome database for influenza viruses, has been created with a web
interface so that users could query for viruses of interest and download complete genome
sequences and metadata of isolates. The interface of the database is publicly accessible at
http://bucatini.bioinformatics.rit.edu/bindhuURMC/.
      Even though it is known that influenza viruses are under constant evolution at the surface
glycoproteins to develop drug resistance or immunity against hosts, little is known whether
influenza viruses are under adaptive evolution within distinct geographical regions. In the
present study, an effort is made to examine whether human influenza A/H3N2 viruses from
distinct geographical regions are under differential positive selection pressures within
hemagglutinin and neuraminidase coding regions, and to identify potential amino acid sites, if
any, that are under such positive selective pressures. Our analyses returned evidence for
strong positive selection as well as differential positive selection acting within the USA
hemagglutinin and weak positive selection acting within New Zealand neuraminidase, at
epitope regions. Based on this evidence we speculate that, in spite of global migration, human
influenza A/H3N2 viruses are under geographically distinct differential selection pressures, to
evade environment driven host immunity. Further research is needed to confirm this
speculation.
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6Introduction
        Influenza, also known as the flu, is an acute respiratory illness caused by viruses.
Symptoms of influenza may include fever, chills, headache, cough, sore throat, runny or
stuffy nose, muscle or body pain, fatigue, anorexia, diarrhea, and vomiting (Zambon 1999).
Each year millions of people worldwide suffer from this highly contagious disease. Influenza
outbreaks usually occur suddenly and then spread through the population creating an
epidemic. According to the CDC, each year in the United States on average 5% to 20% of the
population get the flu each flu season, which typically lasts from November to March. More
than 200,000 people are hospitalized and about 36,000 people die from flu complications.
Sometimes influenza spreads through a population across a larger region like a continent or
even worldwide resulting in a pandemic. Three major influenza pandemics occurred during
the last century killing millions of people (Goldrick et al. 2007). The pandemic H1N1/1918
known as the “Spanish Flu” has been estimated to have caused around 50 million deaths
(Johnson 2002). The other two pandemics in the last century were H2N2/1957 and
H3N2/1968 (Smith et al. 2009). According to the WHO, as of June 27, 2010 more than 214
countries and overseas territories or communities have reported laboratory confirmed cases of
pandemic influenza in this century, H1N1/2009, including over 18239 deaths. The WHO
announced on August 10, 2010 that the H1N1 influenza virus has moved into the post-
pandemic period in which influenza disease activity has returned to levels normally seen for
seasonal influenza.
7Influenza Virus
         RNA viruses of the family Orthomyxoviridae cause influenza. There are three types of
influenza viruses: Types A, B, and C. Even though types A and B viruses cause epidemics,
type A viruses are more pathogenic and are responsible for annual epidemics and occasional
severe pandemics. Type C infection is usually limited to mild respiratory illness and is not
known to result in epidemics (Hampson & Mackenzie 2006). The serotype of the virus is
determined by the type-specific internal proteins: M1 and NP (Hampson & Mackenzie 2006).
Type A viruses are classified into subtypes based on the types of two surface glycoproteins,
hemagglutinin (HA) and neuraminidase (NA) they express. There are 16 anitigenically
distinct hemagglutinin subtypes and 9 different neuraminidase subtypes (Yen & Peiris 2009,
Lu et al. 2007). Natural host for type A viruses are aquatics birds in which they replicate in
the intestine without causing any symptoms and then transmit to a wide range of animals
including birds, humans, horses, and pigs (Zambon 1999). Type B viruses almost exclusively
infect humans whereas type C viruses infect humans and pigs (Zambon 1999, Guo et al.1983).
There are different strains of type A subtypes, type B, and type C viruses. The influenza virus
strains are named by a system that includes: the type of the virus, the host species (if not
human), the place from which the strain was isolated, a laboratory identification number, the
year of discovery, and the subtypes of HA and NA in parenthesis for influenza A virus.
Structure of the Virus
      Influenza A virions exist in different sizes and shapes depending on the strain and passage
history, ranging from filamentous forms typically found in human isolates to spherical forms
(around 100 nm) of laboratory variants (Steinhauer & Skehel 2002). The typical feature of
virions irrespective of their morphology is a layer of tightly packed hemagglutinin (HA) and
8neuraminidase (NA) glycoproteins that project from the viral membranous envelope. In
addition, the viral envelope contains a small amount of matrix (M2) protein. The viral
membrane has a lipid bilayer that is derived from the plasma membrane of infected cells and
just beneath this bilayer is a matrix composed of viral matrix protein (M1). Within the
envelope there are segmented, flexible rod like viral ribonucleoproteins (vRNPs) made up of
four proteins and single stranded negative-sense RNA. The predominant protein of vRNPs is
nucleoprotein (NP) whereas three other polymerase proteins (polymerase acidic protein (PA),
polymerase basic protein 1 (PB1), polymerase basic protein 2 (PB2)) are found in lower
quantities.
Life Cycle of the Virus
The viral life cycle begins when hemagglutinins of the virus attaches to the sialic acid
receptors found on the epithelial cell membrane of the host respiratory tract. This linkage,
α(2,3) or α(2,6) is specific for viruses from different species (Samji 2009). The α(2,6) linkage
is recognized by human strains, whereas the α(2,3) linkage is recognized by avian and equine
strains. Both linkages are recognized by swine strains that may enable swine to act as a
‘mixing vessel’ for avian and human influenza viruses producing novel pathogenic viruses
(Samji 2009). After binding, the virion enters the host cell membrane by endocytosis where
fusion of the viral and endosomal membranes opens up M2 ion channel that makes the virus
acidic. Due to this acidity, vRNPs are separated from matrix M1 and released into the
cytoplasm of host cell. The proteins in vRNPs have nuclear localization signals (NLSs) that
enable vRNPs to bind to the cellular nuclear import machinery and enter the host cell nucleus
(Samji 2009). The negative sense RNA of virus is then transcribed into positive sense viral
mRNA by “cap-snatching” mechanism in which the PB2 protein that has endonuclease
9activity binds to the 5’ methylated caps of host cell mRNAs and cleaves 10 to 15 nucleotides
3’ to the cap structure. This cellular capped RNA fragment is used as a primer for viral
transcription by viral polymerases. Some positive sense mRNAs are exported out of the
nucleus for protein synthesis. Newly synthesized NP, M1, and polymerase proteins are
imported back into the nucleus to help in vRNA replication. The negative sense vRNA is first
converted into positive sense cRNA that act as a template for the production of new genomic
negative sense vRNA. The new vRNAs are then encapsilated by NP protein and exported into
the cytoplasm by nuclear export proteins (NEP) to sites at the host cell surface where lipid
bilayer of the progeny’s viral membrane is derived from the host plasma membrane. New
matrix protein (M1) is acquired, and the glycoproteins (HA and NA) and membrane protein
(M2) that have been synthesized in the ribosomes and exported to the host cell membrane are
incorporated into the viral envelope. The NA proteins cleave the sialic acid residues on the
host cell membrane that bind with newly assembled virion HA proteins and thereby help the
newly formed virions to be released from the host cell by budding.
Influenza Virus Genome
           The influenza virus genome is composed of segmented, single stranded, negative-sense
RNA. Type A and type B viral genomes consist of 8 segments named PB2, PB1, PA, HA,
NP, NA, MP, and NS in the order 1- 8 (Lu et al. 2007). The type C viral genome has 7
segments PB2, PB1, P3, HE, NP, MP, and NS. In influenza A and B viruses, the eight
segments encode eleven proteins: hemagglutinin (HA), neuraminidase (NA), matrix 1 (M1),
matrix 2 (M2), nucleoprotein (NP), polymerase acidic protein (PA), polymerase basic protein
1 (PB1), polymerase basic protein 2 (PB2), polymerase basic protein 1 – F2 (PB1-F2), non-
structural protein 1 (NS1), and non-structural protein 2 (NS2) (Samji 2009).
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           RNA segments 1, 2, and 3 code for the transcriptase-associated proteins PB2, PB1, and
PA respectively. PB1 and PB2 are named after their basic property whereas PA is named due
to its acidic property. Coding regions of PB1, PB2, and PA are 2277, 2271, and 2148
nucleotides long and code for proteins of 759, 757,716 amino acids respectively. PB1 is
involved in initiating transcription and in mRNA synthesis. PB2 is involved in binding to the
cap-structure of host-cell mRNA and in mRNA synthesis. PA is involved in vRNA synthesis.
     Segment 4 of the genome codes for hemagglutinin (HA), the most important viral antigen
against which neutralizing antibodies are directed (Steinhauer & Skehel 2002). HA forms
spikes on the surface of the viral lipid membrane and is made up of subunit HA1 containing a
receptor binding domain and subunit HA2 containing a fusion peptide (Samji 2009). HA is
responsible for the attachment of the virus to the sialic acid containing receptors on the
plasma membrane of the host cell and for penetration of the virus into the cells. The coding
region of 1698 nucleotides codes for 566 amino acids; a hydrophobic signal peptide of 16
amino acids, HA1 of 328 amino acids, and HA2 of 221 amino acids. In most strains there is a
single arginine residue, which is lost on proteolytic cleavage, present at position 329 between
HAl and HA2 domains. Cleavage of HA into HAl and HA2 activates the infectivity of the
virus and is therefore important for the pathogenicity of the virus and the spread of infection
in the host organism (Lamb & Choppin 1983). Antibodies to HA protein are most important
for protection against infection, because these neutralizing antibodies prevent the virus from
entering the host cell and initiating infection (Lin et al. 2010). The HA segment in influenza B
virus is 1882 nucleotides long and codes for 584 amino acids.
     Segment 5 codes for a type-specific nucleocapsid protein (NP) that is used to classify
influenza viruses as A, B, or C (Lamb & Choppin 1983). NP constitutes the main protein of
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the viral ribonucleoprotein complexes (vRNPs) that encapsidate genomic RNA segments and
NP is necessary for viral polymerase to recognize template vRNAs and cRNAs (Steinhauer &
Skehel 2002). In this segment, a coding region of 1494 nucleotides codes for 498 amino acids.
Segment 6 codes for an integral membrane glycoprotein, the neuraminidase (NA). This
segment has a coding region of 1407 nuc1eotides that codes for 469 amino acids. This protein
cleaves sialic acid residues on the host cell glycoproteins and glycolipids to which the HA
proteins of newly assembled virions bind and, therefore plays an important role in the release
of newly formed virions from the host cell membrane (Samji 2009). NA also enables viruses
to reach target epithelial cells by enabling them to elute from inhibitory sialoglycoproteins
present in the respiratory tract (Lamb & Choppin 1983). Antibodies against NA do not
prevent infection with the virus, but reduce the severity of infection by preventing newly
formed viruses from escaping the cell and infecting new cells (Lin et al. 2010).
         Segment 7 codes for two proteins that share a short overlapping reading frame: the
matrix protein (M1) and the transmembrane protein (M2). M1 forms a layer under the lipid
bilayer in the virion envelope and is the most abundant protein in influenza virus (Lamb &
Choppin 1983). The Ml protein plays a role in viral assembly by acting as a bridge between
vRNPs and the viral envelope by forming a domain for vRNPs to bind on the inner surfaces of
the host plasma membrane from which the lipid bilayer of the virion is derived (Nayak et al.
2004, Lamb & Choppin 1983). The M2 protein is an integral membrane protein and functions
as an ion channel that helps in disassembly of the virus during initial stages of infection
(Samji 2009). A reading frame that spans 756 nucleotides codes for 252 amino acids of the
M1 protein and a second reading frame that spans 291 nucleotides and codes for 97 amino
acids of M2 protein (Lamb & Choppin 1981).
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        Segment 8 codes for two nonstructural proteins NSl and NS2 by differential splicing.
The NSl mRNA (unspliced) encodes NSl of 230 amino acids and the NS2 mRNA (spliced
mRNA generated from NSl mRNA) encodes NS2 of 121 amino acids (Bullido et al. 2001).
NSl regulates nucleocytoplasmic transport of the spliced NS2 mRNA and its precursor
(Alonso-Caplen F V et al. 1992). The NS2 protein mediates nuclear export of vRNPs by
acting as an adaptor between viral ribonucleoprotein complexes and the nuclear export
machinery of the cell and is therefore known as the nuclear export protein (NEP) (O’Neill et
al. 1998). Although the NS2 protein was originally considered a non-structural protein, it was
later established to be a part of virions (Bullido et al. 2001).
High Variability of Influenza Viruses
     Influenza A viruses are highly mutable resulting in the appearance of new strains and
subtypes. These changes can be small and continuous (antigenic drift) or large and abrupt
(antigenic shift) (Steinhauer & Skehel 2002). The antigenic drift occurs as a result of the
accumulation of point mutations of viral RNA especially in the genes encoding surface
glycoproteins, assumed to be due to immune selection (Steinhauer & Skehel 2002).Antigenic
drift results in new strains of the virus with altered characteristics. Since these new strains are
not recognized by host’s immune system, antibodies produced against previous viral strains
no longer recognize these new strains and the host organism gets a new infection. This can
lead to an epidemic. The antigenic shift happens when two separate strains of influenza A
viruses from different species simultaneously infect the same host cell. For example, viruses
from humans and birds could coinfect the same pig cell. The genes from both strains undergo
reassortment yielding new hemagglutinin and/or neuraminidase proteins of a new virus strain
or subtype. Most people have little immunity to this new strain or subtype, which can result in
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a more severe epidemic or even a pandemic. Antigenic drift occurs in both influenza A and
influenza B viruses while antigenic shift is seen only in influenza A viruses (Treanor 2004).
Since influenza B viruses infect only humans, there is no gene pool for these viruses in other
animals for antigenic shifts to occur (Webster & Berton 1981).
           There were 3 major influenza pandemics in 20th century: H1N1/1918(Spanish Flu),
H2N2/1957(Asian Flu), and H3N2/1968(Hong Kong Flu). Studies have shown that these
pandemics were caused by genetic reassortment between avian and pre-existing human
viruses (Smith et al. 2009). The H2N2/1957 pandemic strain was introduced when avian HA,
NA, and PB1genes were acquired by a preceding human H1N1 strain, whereas the
H3N2/1968 strain resulted when avian HA and PB1 genes were incorporated into pre-existing
human H2N2 virus (Smith et al. 2009). Even though the evolution of H1N1/1918 pandemic
strain remains ambiguous, evidence suggests that, avian virus gene segments have entered
mammals, probably swine, where reassortment occurred with the prevailing human virus over
the course of time (Smith et al. 2009).
             The emergence of pandemic 2009 virus is considered a unique event in modern
virology since it does not fit the classification of new subtype or drift (Sullivan et al. 2010). It
is not a new subtype because H1N1 viruses have been in continuous circulation since 1977
and is not a drift because the H1N1/2009 viruses have no direct evolutionary relationship with
recently circulating human H1N1 viruses. The H1N1/2009 pandemic virus originated from
the reassortment of six segments from a triple reassortant H3N2 virus and two segments of a
Eurasian H1N1 swine virus (Chang et al. 2009). The novel triple reassortant of swine-origin
H3N2 virus emerged from the reassortment of classical North American swine H1N1 virus
with human H3N2 virus and an avian influenza virus of North American lineage with
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unknown subtype. These tripple assortant viruses have been circulating in the North American
swine population since 1998 and the first human human infection with these viruses was
reported in 2005 (Sullivan et al. 2010).
      The subtypes of influenza A viruses that emerged in 1957 (H2N2) and 1968 (H3N2)
replaced pre-existing subtypes. However, the H1N1 subtype that reappeared in 1977 and was
related closely to 1950 virus strains did not replace preceding H3N2 subtypes. Thus, influenza
A subtypes H1N1 and H3N2 have been co-circulating with influenza B viruses since 1977
and therefore, influenza A subtypes H1N1 and H3N2 and influenza B strains are included in
the influenza vaccine (Hay et al. 2001). Although antigenic shift happens only occasionally,
antigenic drift happens more frequently enabling the virus to re-infect populations by
continually evading host immunity through the rapid evolution of surface antigens (Fitch et
al. 1997). Due to the more frequent nature of antigenic drift, one or two of the three strains of
each year’s influenza vaccine is updated to keep up with it.
Influenza Genome Sequence Project and Databases
      To understand influenza viruses through knowledge of their genome, a collaborative effort
known as the Influenza Genome Sequence Project, funded by National Institute of Allergy
and Infectious Diseases (NIAID), was started in 2004 to sequence flu virus isolates collected
from all over the world from variety of host species; humans, birds, pigs, and other animals. A
major part of the sequencing is conducted by the Genome Sequencing Center at the J. Craig
Venter Institute (JCVI) and after annotation at the National Center for Biotechnology
Information (NCBI), data is released into GenBank; an NIH-funded, public, searchable online
database. By initiating such a project, project leaders hope that researchers could use that
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information to gain better understanding of the evolution, infectivity, spread, and virulence of
the viruses. Such knowledge may be useful to study annual flu epidemics, to predict the
emergence of pandemic flu viruses, or to develop new vaccines and drugs for flu. According
to NIAID, as of August 5, 2010, 5531 human and avian isolates have been completely
sequenced and made publicly available through GenBank. In addition, these sequence data are
also available for bulk download at the JCVI’s Genome Sequencing Center website.
          Increasing amounts of genomic data available from influenza virus genome sequencing
projects has led to the establishment of a few databases containing the sequences and
metadata about the isolates. The influenza Virus Resource by the NCBI integrates sequence
data from the Influenza Genome Sequencing Project and GenBank with applications for
sequence analysis and annotation. In addition to database browsing and sequence retrieval,
there are tools for complete genome sets finding, BLAST, multiple sequence alignment,
annotation, and cluster or phylogenetic tree building. More over, there are links to other
resources that contain flu sequences, related publications, and general information about flu
viruses. Influenza Research Database (previously BioHealthBase/Influenza), a collaboration
between Northrop Grumman Health and Human Services, University of Texas Southwestern
Medical Center, Vecna Technologies, Los Alamos National Laboratory, University of
California (Davis), Sage Analytica, and NIAID/DMID integrates analysis tools with a variety
of influenza research data such as avian and human surveillance data, genomics, experimental
epitope information, data from assays of virulence, transmission, and host range into a single
resource. The influenza Virus Database (IVDB) by Beijing Institute of Genomics (BIG) and
Chinese Academy of Sciences hosts complete genome sequences of influenza A virus viruses
collected from different parts of China that have been sequenced by BIG, and curates all other
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published influenza virus sequences, along with providing tools for sequence analyses. There
are also private databases like the Influenza Sequence Database (ISD), an influenza sequence
database for those involved in a work-for-others contract with Los Alamos National
Laboratory. These public and private databases serve as valuable resources to study the
continuously changing nature and evolution of flu viruses by comparing different strains
collected from varying sources such as geographically diverse populations, different species,
and various epidemics to develop new flu vaccines and drugs.
RIT Influenza Virus Database
      Even though the above-mentioned resources contain large amounts of data and useful
analytic tools, the database query and data retrieval have some limitations. In the Influenza
Virus Resource, search for a keyword is limited to fields entitled strain name, sequence
pattern, and drug-resistance mutation. Moreover, only default fields are displayed and there
are no options to sort the results. In the Influenza Virus Database (IVDB) additional fields
could be displayed and query results could be sorted, but only sequences, not the information
about the isolates can be downloaded. Downloading the sequences for isolates of interest is
very complicated in this database. In order to download the sequences, the user has to click
the ‘Add to Worksheet’ button after selecting the rows and then click the download button
which will open another page with a link to be clicked for download. If the user selects
different rows for another download, first ‘Clear Worksheet’ button has to be clicked before
repeating the above steps, otherwise sequences from the previous selection will be
downloaded. Compared to others, the Influenza Research Database (IRD) has provided more
options for query and display; however, some of these features are not easily noticeable on the
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web interface. For example, the keyword search and display options are given as a drop-down
list in the advanced search section and sort options are one more level down under display
options. Since there is no selectable name list to select the subtypes, the user has to be familiar
with influenza virus subtypes in order to enter a search value in the subtype field. Even if
query results could be limited by entering the minimum length of the sequences, no option is
given to limit the query by maximum length. Therefore, an attempt has been made to create a
comprehensive web-based database to organize the genomic data and metadata of influenza A
and B viruses available at the JCVI’s Genome Sequence Center website. This searchable
database, named RIT Influenza Virus Database, has features to query influenza virus isolates
of interest using different criteria and to download information about isolates in different
formats including nucleotide sequences in FASTA format. In addition, there are links for easy
navigation to complete genome assembly files in FASTA format and to corresponding entries
for those isolates in Genbank, Trace Archive, and Taxonomy Browser at the NCBI. We are
hoping that such a resource would be beneficial to researchers who are interested in influenza
virus study.
Geographical Influenza Activity and Selection Pressures
       In temperate regions influenza epidemics usually happen in winter, from November to
March in the northern hemisphere and from May to September in the southern hemisphere.
Though influenza viruses have been considered “coldweather” pathogens for long time, it is
now known that tropical regions show year around influenza virus activity (Nelson et al.
2007). Tropical regions are considered permanent mixing pools of viruses from around the
world, and South East Asia is especially known as the epicenter for the emergence of
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pandemic viruses (Nelson et al. 2007). Tropical regions are also considered ideal source
populations for selection pressures due to extended periods of viral transmissions in this
population (Rambaut et al. 2008). It has been suggested that the antigenic changes in
temperate regions are secondary effects of gene flow from the ideal source population of
tropical regions (Rambaut et al. 2008). However this hypothesis has not been tested due to a
lack of abundant data from tropical regions.
       Factors that influence the winter seasonality of influenza viruses in temperate regions
remain poorly understood (Nelson et al. 2007). The following different modeling theories
have been proposed to explain the seasonality of influenza activity (Lofgren et al. 2007). It
has been suggested that the observed seasonality of influenza is due to a seasonal decrease in
host immunity rather than sweeping waves of infection going across the world. Biological
factors such as changes in photoperiod or a lack of nutrient intake are thought to reduce host
immunity. Many social and environmental factors are also attributed to the seasonality of
influenza infection. Crowding increases the chances of person-to-person transmission of viral
particles through the air and thus increases the potential for spread of infection. Decreases in
ambient temperature are associated with increases in seasonal influenza infection. Although
there is no direct biological justification for this, a decrease in temperature causes behavioral
changes such as crowding. Indoor heating causes low humidity and circulation of the same
body of air that favors persistence of viral particles in the environment. It has been suggested
that atmospheric and climatic changes due to El Niño cause bulk aerosol transmission and
crowding that favor seasonality. Air travel has been proposed as another leading cause of the
simultaneous appearance of hemisphere wide influenza as opposed to the theory of local
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influenza evolution. However, virological and epidemiological evidence are lacking to
support this.
          Rambaut et al. (2008) analyzed HA and NA genes of influenza A/H3N2 isolates from
New York representing the northern hemisphere (1992-2005) and from New Zealand
representing the southern hemisphere (1999-2006) by a Bayesian Markov Chain Monte Carlo
approach and inferred that genetic diversity in these populations peak in the winter months in
each hemisphere. In order to explain this genetic diversity, they analyzed the data
phylogenetically and the results showed few direct phylogenetic links between viruses in
successive seasons from same geographical locations. They hypothesized that the genetic
diversity in temperate populations is the secondary effect of selection within and migration
from the source population of tropical regions, rather than ‘in situ’ evolution within each
temperate population. However, this hypothesis has not been tested due to lack of abundant
data from the tropical regions. Similarly, from the phylogenetic analysis of HA and NA genes
of influenza A/H3N2 viruses (2000 –2005) from New York representing northern hemisphere
and from New Zealand and Australia representing southern hemisphere, Nelson et al. (2007)
inferred that seasonal influenza A viruses do not regularly evolve in geographic isolation
between epidemic seasons, instead viruses migrate away between the hemispheres during the
non-epidemic summer months and are reintroduced in winter. However, if migration is the
main reason for genetic diversity in influenza viruses of temperate regions we would expect
more influenza activity in the summer months due to increase in travel, which increases the
chances for cross-hemisphere migration as well as migration from ideal source population of
tropical region. On the contrary, in these temperate regions epidemics are common in winter
instead of summer. Therefore, it is logical to agree to with the speculation of Nelson et al.
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(2007) that, even if global migration of influenza viruses is unavoidable, some factors that are
local trigger seasonal epidemics. If viruses evolve elsewhere and migrate to the temperate
regions instead of undergoing local adaptive evolution, influenza viruses from both
hemispheres will be showing similar selection pressures. In converse, if local adaptive
evolution occurs in temperate regions, viruses from different locations may have differential
selection pressures. It is possible that geographically distinct positive selection pressures
acting at the molecular level may not be captured by phylogenetic analysis alone, but those
intrinsic processes may be captured by codon level analyses. So far, there has been no
published work on selection pressure analyses by site-by-site comparisons of codons of
influenza viruses from various geographical locations for collecting evidence of potential
environment-driven differential selection pressures. Selection pressure analyses have been
used to predict emerging strains that could cause epidemics (Bush et al. 1999) or to look for
evidence of host-driven adaptive evolution in HA gene of human influenza viruses (Shen et
al. 2009). It has been shown by site-by-site comparison of codons in multiply aligned
sequences of HA gene of human influenza A/H3N2 virus that the virus is under positive
selection at antibody-combining codon sites (Ina & Gojobori 1994, Yang 2000). Kosakovsky
et al. (2006) have employed codon-based maximum likelihood methods in HIV virus coding
sequences for identifying codon positions that are under selection pressures in particular
geographical population as well as under differential selection pressures between populations.
By conducting a similar study in segments/genes of influenza A viruses from different
geographical locations, we hope to gain insight into the influence of environment in the
adaptive evolution of influenza viruses and influenza activity on a global scale. For that
purpose, codon based selection pressure analyses have been employed within HA and NA
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coding regions of human influenza A/H3N2 virus isolates from USA, New Zealand, and
Australia to look for evidence of positive selection in individual geographical population and
of differential positive selection between populations, and to identify potential amino acid
sites that are under positive selection if evidence of positive selection is returned. Even if
tropical regions show year round influenza activity, enough data was not available from those
countries for meaningful comparative analyses.
Codon Based Selection Pressure Analysis
     Estimation of synonymous and nonsynonymous substitution rates per site between
nucleotide or amino acid sequences is fundamental for the study of molecular sequence
evolution (Ina 1995).  The rate of accumulation of synonymous substitutions (dS) is largely
controlled by mutation rate whereas the rate of nonsynonymous substitutions (dN) may be
influenced by selection (Burrows et al. 2004). Therefore, the ratio of the rates of
nonsynonymous and synonymous substitutions (omega ω) is used to test whether a protein-
coding gene has evolved under different selective pressures (Burrows et al. 2004). When there
are no restrictions on amino acid substitutions at codons under no selection, it is expected that
the accumulation of nonsynonymous and synonymous substitutions occur at the same rate. At
those codon positions dN/dS (ω) =1 indicating neutral selection. For codons where amino acid
changes lead to lower fitness, nonsynonymous changes accumulate at a slower rate and
therefore the ratio will be less than one (ω < 1) indicating negative (purifying) selection.
Codons under such strong negative selection where amino acid changes are not tolerated
would have a ratio of zero (ω = 0). While, in codons under positive selection where amino
acid changes are promoted by selection, the nonsynonymous substitution rate is higher than
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that of synonymous substitution making the ratio greater than one (ω > 1) (Burrows et al.
2004). Therefore, comparisons of fixation of these two types of substitutions are important in
understanding the mechanism of sequence evolution (Yang 1998).
      There are different methods for estimating the synonymous and nonsynonymous
substitution rates per site. Two popular methods for detecting positive selection in protein
coding genes by estimating the nonsynonymous/synonymous rate ratio are parsimony
methods and maximum likelihood methods (Anisimova et al. 2002). In parsimony methods,
substitutions are inferred using parsimony reconstructed ancestral sequences where
reconstructed and observed sequences are compared in a pair-wise manner to estimate the
numbers of synonymous and nonsynonymous substitutions per site along each branch in the
phylogenetic tree (Anisimova et al. 2002). The parsimony method by Fitch et al. (1997)
compared dN/dS ratio at each site against the average dN/dS ratio along the sequence, while
method by Suzuki and Gajobori (1999) compared that against the neutral expectation 1
(Wong et al. 2004). The maximum likelihood methods by Nielsen and Yang (1998) and Yang
et al. (2000) avoid using reconstructed ancestral sequence for estimating dN and dS. Instead,
they use a likelihood method that averages over all possible ancestral sequences at each
interior node weighted according to their relative likelihoods of occurrence (Anisimova et al.
2002). In actual nucleotide sequences the mutational rates among the four nucleotides are not
equal where transitional mutations occur more frequently than transversional mutations. The
reconstructed ancestral sequences using parsimony involve systemic bias and random errors,
whereas the likelihood methods are based on more realistic models of sequence evolution that
account for transition/transversion rate bias, genetic code structure, and different base
frequencies at codon positions (Yang 1998). The parameters estimated by maximum
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likelihood methods include branch lengths of the tree, transition/transversion rate ratio (k),
and dN/dS ratios (ω) using a numerical iteration algorithm with different starting values.
Several codon-based maximum likelihood models are implemented in the CODEML program
in the PAML package for estimating the parameters and for testing different assumptions of
selection pressures and their statistical significances (Yang 1997). PAML is a package of
programs for phylogenetic analyses of DNA or protein sequences using maximum likelihood.
It is available at http://abacus.gene.ucl.ac.uk/software/paml.html.
     The most basic model in CODEML is called a ‘branch model’. The simplest branch model
known as the ‘one-ratio’ model (M0) assumes the same ω ratio for all lineages in the
phylogeny while the ‘two-ratio’ model (M2) assumes that the lineage of interest (foreground
branch) has a dN/dS ratio (ω1) different from the dN/dS ratio (ω0) of other lineages (background
lineages) in the tree. Likelihood ratio tests (LRT) are employed to examine the assumptions of
different models. The one-ratio (M0) and two-ratio (M2) models can be compared to test
whether allowing two different ω ratios for foreground and background lineages better fit the
data than does allowing single ω ratio for all lineages. To estimate the significance, likelihood
ratio tests (LRTs) are conducted where twice the log likelihood difference between the null
and alternate models are compared with a χ 2 distribution with degree of freedom (df) equal to
the difference in the number of parameters estimated from the data for each model. The one-
ratio model (M0) and two-ratio model with fixed omega (M2 Null) are null models, whereas
the two-ratio model (M2) is the alternate model. If the p-value is less than 0.05 it can be
inferred that the alternate model fits the data better than the null model with 95% significance
level.
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       In branch models, the ω ratio has been calculated as an average over all codon sites in a
gene and over the entire time period that separate the sequences. This model is found to be a
stringent one for detecting positive selection since in many proteins most of the amino acid
sites are invariable due to functional constraints with ω close to zero, whereas adaptive
evolution can occur at a few amino acid sites at a few time points. The ω ratio averaged over
all codon sites and over time may not be significantly greater than one (Nielsen & Yang 2000,
Yang et al. 2000). Therefore, a number of site models have been implemented in the
CODEML that allow heterogeneous ω ratios among site-classes to identify critical amino
acids that are under positive selection (Nielsen & Yang 2000, Yang et al. 2000). LRT
compares a null model that does not allow site-classes with ω > 1 to an alternate model that
allows site-classes with ω > 1.  The null model M1a (NealryNeutral) assumes two classes of
sites: sites with weak purifying selection with 0 < ω < 1 and completely neutral sites with
ω1=1 with proportions p0 and p1 (1-p0) respectively.  The alternate model M2a
(PositiveSelection) adds a proportion (p2) of site class with ω2 > 1 estimated from data.
Another LRT compares a null model M7 (beta) that assumes a beta distribution of ω (0 < ω
<1) for 10 site classes with an alternate model M8 (beta& ω) that adds an additional class of
positively selected sites with ωs > 1. Positive selection is inferred if LRT is significant. The
alternate model M8 (beta& ω) can also be compared with a null model M8a (beta& ω fixed at
1) to test for positive selection. Posterior probability that each site is from a particular site-
class is calculated by a Bayes Empirical Bayes (BEB) approach and the amino acid sites with
higher posterior probability (Pb > 95%) that they belong to site-classes with ω >1 are inferred
to be under positive selection.
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        The branch specific models assume variation in ω between lineages but no variation in ω
among sites. The site-specific models allow the ω ratio to vary among sites but not among
lineages. A third class of models, branch-site models, allow the ω ratio to vary among
lineages as well as among sites where lineages are determined a priori into foreground and
background lineages like the branch models (Yang 2002, 2005). The model A of branch-site
model assumes four site-classes in the aligned sequences where the first class of sites is highly
conserved in all lineages with 0 < ω0 < 1 and the second class of sites is under neutral
evolution throughout the tree with ω1=1. Site classes 2a and 2b are conserved (0 < ω0 < 1) or
neutral (ω1=1) in the background branches, but are under positive selection in the foreground
branches with ω2 > 1. The four parameters in the ω distribution for this model: p0, p1, ω0, and
ω2 are estimated from the data by maximum likelihood. Model A is the alternative hypothesis
for two LRTs under the branch-site model, test 1 and test 2. In test 1, the null hypothesis is the
site model M1a, that assumes two site-classes in the alignment with 0 < ω0 < 1 and ω0 = 1 for
all branches. Significance of this test can be caused either by relaxed selective constraint on
the foreground branches like presence of sites with ω < 1 on the background branches and ω =
1 on the foreground branches or by positive selection along the foreground branches. The null
hypothesis for test 2 is the branch-site model A with ω2 = 1 fixed on the foreground branches.
This null model allows sites evolving under negative selection in the background lineages to
be released from constraint to evolve neutrally on the foreground lineages. Therefore, test 2 is
considered as a direct test for positive selection on the foreground lineages.
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Materials and Methods
RIT Influenza Virus Database
      The RIT Influenza Virus Database was created on a MySQL server (v 5.1.47) running on
the UNIX Server bucatini.bioinformatics.rit.edu. The genome data and the metadata of
influenza A and B virus isolates were downloaded from the J.Craig Venter Institute’s
Microbial Sequencing Center website (http://gsc.jcvi.org/projects/msc/influenza/). These data
were then normalized into tables in the RIT Influenza Virus Database. PHP, an open-source
server side scripting language available for various platforms, was used to create the tables.
The advantage of PHP over other technologies is that it is free, easy to code, and execute.  In
addition, PHP integrates well with the MySQL database server.
          The database has three tables: StatusA, StatusB, and SequenceAB (Tables 1, 2, 3).
Since the status data downloaded for influenza A and B virus isolates were in different
formats, two different but similar scripts were used to read the Excel files containing metadata
to create the tables StatusA and StatusB to store information of A and B virus isolates
respectively. The statusA table has the following fields: count, Type, Strain, Status, Fasta, Id,
Taxonomy, Trace, Genbank, Subtype, Year, Country, District, Age, Gender, Host,
PassageHistory, and ExtractionMethod. For this table, primary key ‘Id’ was created from a
substring of the Fasta field that uniquely identifies each virus isolate even when some isolates
share the same strain name but have different extraction methods. The same fields were
created for StatusB table even though the Excel file carrying status data for B viruses did not
have values for Fasta, Taxonomy, Trace, and Genbank. Since there were no values in the
Fasta field to create values for the ‘Id’ field in the StatusB table, strain name was used as
primary key. There were few identical strain names in the status data due to more than one
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extraction method, so those rows were removed to avoid ambiguity for B viruses. Nucleotide
sequences of A and B viruses were stored into the table SequenceAB and primary key of this
table named ‘PrimaryId’ was created from a substring of the header that is unique for each
sequence. To join SequenceAB table with StatusA and StatusB tables two other fields were
created in the SequenceAB table. A substring of ‘PrimaryId’, which is unique for each virus
isolate but same for all segments of the same isolate, was used for creating the field ‘Id’ that
matches with the primary key of StatusA table. Since there is no ‘Id’ field in the StatusB
table, another field called ‘Strain’ which matches with the primary key of  the StatusB table
was also created from the header. Segment names, length of the sequences, sequences, and
headers were also stored as fields in the SequenceAB table.
Table 1 Description of StatusA table in the database
StatusA
Field Type Description
Id varchar(50) Primary key. Unique for each virus isolate. Substring of
the Fasta field values.
Strain varchar(100) Strain name of the isolate. Shared by isolates with same
strain name, but different extraction method.
Type char(1) Type of the virus.
Subtype varchar(10) Subtype of the virus.
Year char(4) Year of virus isolate.
Country varchar(50) Country from where the isolate was collected.
District varchar(50) District from where the isolate was collected.
Host varchar(50) Host from which the isolate was collected.
Age varchar(5) Age of the host.
Gender varchar(2) Gender of the host.
PassageHistory varchar(50) Passage history of the isolate.
ExtractionMethod varchar(50) Extraction method of the isolate.
Fasta varchar(300) Hyperlink to complete genome sequence files.
Genbank varchar(500) Hyperlink to complete genome sequence files in Genbank.
Trace varchar(300) Hyperlink to the Trace Archive in the NCBI.
Taxonomy varchar(300) Hyperlink to the Taxonomy in the NCBI.
count int(11) Sequential number in which records were inserted into the
database. Created to locate the record in the Excel file
from which data was inserted into the table.
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Table 2 Description of StatusB table in the database
StatusB
Field Type Description
Id varchar(50) No value. Fasta field from which Id field was created for
A viruses do not have values for B isolates in the data file.
Strain varchar(100) Primary key. Strain name of isolate. Few isolates in the
downloaded data had same strain name, but different
extraction method. So they were not inserted into the
database to avoid mapping to the wrong sequence.
Type char(1) Type of the virus.
Subtype varchar(10) No subtypes for B viruses, so value is ‘-‘ for all records.
Year char(4) Year virus was isolated.
Country varchar(50) Country from where the isolate was collected.
District varchar(50) District from where the isolate was collected.
Host varchar(50) Host from which the isolate was collected.
Age varchar(5) Age of the host.
Gender varchar(2) Gender of the host.
PassageHistory varchar(50) Passage history of the isolate.
ExtractionMethod varchar(50) Extraction method of the isolate.
Fasta varchar(300) No value because no entry in the data file.
Genbank varchar(500) No value because no entry in the data file.
Trace varchar(300) No value because no entry in the data file.
Taxonomy varchar(300) No value because no entry in the data file.
count int(11) Sequential number in which records were inserted into the
database. Created to locate the record in the Excel file
from which data was inserted into the table.
Table 3 Description of SequenceAB table in the database
SequenceAB
Field Type Description
PrimaryId varchar(50) Primary key. Substring of the sequence header. Unique for
each sequence in the table.
Id varchar(50) Substring of the sequence header. Unique for each virus
isolate, but same for all 8 segments. Field to join with
SequenceA table.
Strain varchar(100) Strain name of an isolate. Substring of the sequence header.
Same for all 8 segments of an isolate. Field that joins with
SequenceB table.
Header varchar(300) Header of the sequence.
Segment varchar(10) Segment of the virus genome with segment number
Gene varchar(10) Gene name of the sequence.
Sequence varchar(3000) Nucleotide sequence.
Length int(11) Length of the nucleotide sequence.
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The database schema is shown in figure 1.
Figure1 RIT Influenza Virus Database Schema
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The interface of the database was created using PHP as well. On the homepage, there are
two forms for submitting user query: one for keyword search and another for advanced
search. The PHP scripts that handle the forms connect to the database and query the database
tables based on user input. The user input values are stored as variables so that they could be
passed across pages when search results need to be displayed as multiple pages. Since PHP
has security issues, data integrity is maintained by checking user input values for SQL
injections using the function mysql_real_escape_string. Data retrieved from the database is
transformed first into a XML string where column names are retrieved to make child nodes
and column values are used for text nodes except when the value is a URL; in that case the
URL is used as an attribute of the child node and the text ‘Link’ is used to create the text
node. The XML document is then transformed by XSLT into HTML to display on the web
page. The XSL stylesheet contains HTML tags that create the page framework, download
buttons, and navigation to other pages in addition to the templates for transforming the XML
document and pagination links. The XML string is also transformed by a different XSL
stylesheet into different formats such as Tab-delimited and Excel for downloading. An XML
Schema has been used to define the data in the XML file. Therefore, if the data need to be
send the contents could be interpreted by a receiver the way they are defined. Javascript
functions are used to select/unselect the records to be downloaded from all pages or from the
current page.
       The scripts that handle the keyword and advanced searches are similar except in the
variables that store the user input values and the included database searching scripts.  Once
the results are displayed on the web page, if the user chooses to download all records from all
pages by checking the ‘SelectAll’ checkbox or only the records from the current page, scripts
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handle the download depending on the format of download. If the format for download is
XML and ‘SelectAll’ is checked, the string that has already been created after database query
is sent to the header for download. Otherwise, if records from the current page are selected, a
new XML document is created for the selected records from the original XML document. If
the format for download is either Tab-delimited or in Excel format, the XML string is
transformed into text or Excel format according to the specifications on a different XSL
stylesheet. If the format for download is FASTA, header and sequences are retrieved from the
SequenceAB table and wrote onto a file in the FASTA format and sent to the header for
download. Finally, if the user clicks any of the download buttons without selecting any
records an error message is displayed.
Analysis of Selection Pressures
      Human influenza A/H3N2 viruses collected during the period 2001 to 2005 from the
countries of the USA, New Zealand, and Australia were used for selection pressures analyses.
This time frame was chosen because of the availability of reasonably large sample sizes from
three different temperate regions. Not enough data was available from the tropical regions for
this time period for comparative analyses. In the USA dataset almost all, except 6-7, of the
isolates were from New York State, while datasets from Australia and New Zealand had
almost even representation from the available regions. Since the sequences downloaded from
the JCVI used for creating the RIT Influenza Virus Database were of nucleotides, full length
coding region sequences for HA and NA proteins from Australia, New Zealand, and USA
were downloaded from the Influenza Virus Resource after collapsing identical sequences.
Sequences with ambiguous characters were excluded from analyses. Thus, the number of
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sequences that constituted each dataset is as follows: for HA coding region: Australia (107),
New Zealand (270), and USA (273) and for NA coding region: Australia (79), New Zealand
(371), and USA (166). Selection pressure analyses were conducted separately for HA and NA
coding sequences. First, each dataset was tested individually for evidence of positive
selection. For this, after removing stop codons, datasets from each country were aligned in the
Phylip format using a web-based tool MUSCLE available at the URL
http://www.ebi.ac.uk/Tools/msa/muscle/. Each multiple sequence alignment was then checked
to make sure there are no gaps. The alignment consisted of 566 codons for HA and 469
codons for NA. For each dataset, a neighbor-joining tree was created for coding sequences
using the programs DNADIST and NEIGHBOR in the package PHYLIP (v. 3.69) with
default settings. PHYLIP, a free package of programs for inferring phylogenies, was
downloaded from the site http://evolution.genetics.washington.edu/phylip.html. Codon
substitution patterns in the alignments were evaluated under different evolutionary models as
implemented in the CODEML (PAML v. 4.4) using the phylogenetic tree topology created for
each dataset. First, model M0 that assumes uniform ω ratio across all sites on all lineages was
ran in CODEML. For running site-specific models M1a, M2a, M7, M8, and M8a, topology
with branch lengths fixed to maximum likelihood estimates from model M0 was used to save
computational time as recommended. The F3x4 model of codon frequencies was used.
           For comparative selection pressure analyses, all pair-wise combinations of the three
geographical datasets were compared using branch and branch-site models for HA and NA
coding regions. In branch and branch-site models, the branches of the phylogeny are labeled a
priori into foreground and background branches where only the foreground branches are
expected to have positive selection. For the ease of labeling the branches, only a sample size
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of 50 sequences was taken from individual geographical population for each coding region.
For any pair, 100 sequences representing two populations were aligned by MUSCLE in
Phylip format and the neighbor-joining tree created by PHYLIP was labeled as foreground
and background branches. Each geographic population was treated as a foreground branch in
turn and compared with each of the other two populations to test whether positive selection
exists in that population in comparison with the other. Thus, six pairs were compared for each
coding region.
Results
RIT Influenza Virus Database
    The RIT Influenza Virus Database is accessible at the following URL:
http://bucatini.bioinformatics.rit.edu/bindhuURMC/. The interface of the database is a
dynamic, cross-browser compatible website which can be used to search, view, and download
influenza virus data. Figure 2 shows the home page of the RIT Influenza Virus Database.
Figure 2 Web interface for searching the RIT Influenza Virus Database
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The homepage can be used to query the database in two ways: keyword search and
advanced search. The ‘Keyword Search’ allows entering any word or number in the text field
provided and returns records that contain the word or number in any of the fields in the
database or in the specific field chosen from a selectable list. If no match is found a message
is displayed. The ‘Advanced Search’ has three sections for selecting options: for search,
display, and sort. For search options there are five selectable fields: type, subtype, host,
country, and segment. Multiple names for each field could be selected simultaneously by
holding down the ‘Ctrl’ key.  In addition, there are two text boxes to enter a range of years
during which the viruses were isolated and two text boxes to enter a length range of segments
to narrow down the query further. The default fields for displaying search results are Strain,
Type, Subtype, Host, Country, Segment, Length, Year, and links to Genbank, Fasta files,
Trace Archive, and Taxonomy at the NCBI. The user could choose the fields to be displayed
by selecting the check boxes in the ‘Display Options’, where in addition to the default fields,
fields such as District, PassageHistory, ExtractionMethod, Age, and Gender are available. The
search results could be sorted in the ascending or descending order by up to three fields where
the fields can be selected from three drop-down lists. If there is no match for a query a
message is displayed, otherwise results are displayed as table rows on a different web page
(Figure 3). If more than 50 records are returned, they are displayed across multiple pages with
each page consists of at most 50 observations. There are pagination links at the top and
bottom of each page for convenient navigation.
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Figure 3 Query result display and download page
        On each page where results are displayed, there is a section for downloading the search
results with four buttons labeled “XML”, “Tab-delimited”, “Excel”, and “FASTA” to select
the format of download (Figure 3). Sequences and metadata of segments of interest for
download can be selected by checking the boxes on the left of each row. In addition, there is
an “All” checkbox to select all records from the current page and a “SelectAll” checkbox to
select all records from all pages for download. The nucleotide sequences corresponding to the
selected segments of isolates can be downloaded in the FASTA format by pressing the
"FASTA” button and the metadata about the isolates could be downloaded in the formats
XML, Tab de-limited, and Excel by clicking the corresponding buttons. Moreover, the
complete genome sequences for a virus isolate can be accessed through the Fasta link in each
row. The difference between this and the FASTA download button is that, complete genome
sequences for a virus isolate can be accessed through Fasta link while all 8 segment rows have
36
to be selected before pressing the FASTA button to download complete genome sequences for
that isolate. However, if the user wants only sequences of specific segments selecting the
corresponding rows will be easier. There is also an option for new search from each page.
Other pages in the website include a page with information about influenza virus, a
documentation page, and a page with links to other useful sites about influenza virus. The RIT
Influenza Virus Database currently contains 28085 sequences where 26901 are from influenza
A isolates and 1184 are from influenza B isolates.
Selection Pressure Analyses on Individual Populations
For each geographic dataset, the likelihood ratio values (lnL) and the estimates of
parameters returned from different site-specific models in the CODEML were used to test
different assumptions where M1a (NearlyNeutral), M7 (beta), and M8a (beta&  fixed) are
null models and M2a (PositiveSelection) and M8 (beta& ) are alternate models. Likelihood
ratio tests (LRTs) were conducted to compare three pairs of site-specific models: M1a and
M2a,M7 and M8, and M8a and M8. To test the statistical significance of a LRT, likelihood
ratio statistic (LRS), calculated from twice the difference of likelihood ratio estimates (lnL)
between null and alternate models, was compared with a χ2 distribution with degree of
freedom (df) equal to the difference in number of parameters estimated between the models.
P-value of 0.05 was set as the cut off point for statistical significance. Table 4 lists the
likelihood ratio statistics and p-values of the site-specific models for HA and NA datasets.
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Table 4 Likelihood Ratio Tests for site-specific models of HA and NA datasets.
N-Number of sequences, LRS-likelihood ratio statistic, df-degree of freedom, P-p-value
Hemagglutinin (HA) USA
       Model M2a, which assumes three site-classes (weak purifying selection site-classes with
0 < ω < 1, completely neutral site-classes with ω1=1, and positive selection site-classes with
ω2 > 1), suggested that 0.4% of sites are under positive selection with ω = 6.6 (Table 5). To
examine the statistical significance of this, model M2a was compared with model M1a that
assumes two site-classes (weak purifying selection site-classes with 0 < ω < 1 and completely
neutral site-classes with ω1=1) using a LRT and the test statistic 2  = 2 x ((--6421.829734) –
(-6437.813530)) = 31.968 with df = 2 gave p-value (P) < 0.001 (Table 4). Since P < 0.05, the
null model was rejected in favor of the alternate model and it could be inferred that model
M2a fit the data significantly better than M1a and the assumption of existence of site-classes
with positive selection in USA HA dataset was supported. For M2a, Bayes Empirical Bayes
(BEB) analysis identified sites 236 R and 242 V as positively selected with posterior
M1a Vs. M2a
(df=2)
 M7 Vs. M8 (df=2) M8a Vs. M8
(df=1)
    Dataset N
    LRS   P    LRS      P     LRS       P
USA (HA) 273 31.968 <0.001 35.746 <0.001 27.483 <0.001
Australia (HA) 107 0.0006 0>0.995 0.079 0.961 0.0376 0.846
New Zealand (HA)
(HA)
270 0.0 1 0.694 >0.995 0.0 1
US  (NA) 166 0.0 1 0.0 1 0.0 1
Australia (NA)  79 0.0 1 0.0 1 0.0 1
New Zealand (NA) 371 3.407 0.182 7.153 0.028 18.832 <0.001
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probability of 100% and 97.6 % respectively. The model M8 suggested 0.5% of sites to be
under positive selection with ω = 5.9 (Table 5). When the models M7 (site-classes with beta
distribution of ω with 0 < ω <1) and M8 (beta distribution plus site-class with ω > 1) were
compared, the p-value was less than 0.05 for LRS 2  = 35.7 and df = 2. Therefore, model
M8 was favored over M7. When M8 was compared with the null model M8a (ω constrained
to 1) LRS = 27.5 with df = 1. This test follows a null distribution that is the 50:50 mixture of
point mass 0 and χ2 where critical values are 2.71 at 5% and 5.41 at 1% (as opposed to 3.84
for 5% and 6.63 for 1% for χ2 distribution). The test static 27.5 is greater than the critical
value 2.71 and therefore M8a was rejected in favor of M8. To avoid violations of model
assumptions it was recommended to use χ2 distribution as well for this test. The p- value for
χ2 distribution was less than 0.05 and thus, M8a was rejected in favor of M8 again. Therefore,
it was inferred that there was enough evidence with great statistical significance to support the
assumption that there are site-classes with positive selection in USA HA dataset. For model
M8, Bayes Empirical Bayes (BEB) analysis identified sites 236 R, 242 V, and 245 R as
positively selected with posterior probability 100%, 99.5 %, and 96.7 % respectively.
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Table 5 USA HA Dataset (273 Sequences) Selection Pressures
p: Number of parameters
Model p Log-
likelihood
Values (lnL)
Estimates
of
Parameters
Positively
Selected Sites (BEB)
(*: P>95%; **: P>99%)
M0 (One-ratio) 1 -6514.717922 =0.256 Not allowed
M1a (NearlyNeutral) 3 -6437.813530 p0=0.850p=0.150
0=0.076( 1=1)
Not allowed
M2a (PositiveSelection) 5 -6421.829734 p0=0.846p1=0.151p2=0.004
0=0.079( 1=1)
2=6.58
10 I      0.563
16 A     0.644
19 L      0.809
61 S 0.636
65 G       0.531
175 Y     0.549
202 G     0.770
209 N     0.695
   236 R     1.000**
  242 V      0.976*
245 R      0.865
320 A     0.712
546 A     0.626
M7 (beta) 3 -6441.940486 p=0.134
q=0.467
Not allowed
M8 (beta& ) 4 -6424.067462 p0=0.995p=0.171
q=0.615
(p1=0.005)=5.91
10 I       0.779
16 A      0.835
19 L      0.923
31 L      0.512
61 S      0.865
65 G      0.753
66 E      0.682
154A     0.569
175 Y    0.717
202 G    0.926
209 N    0.895
   236 R    1.000**
   242 V    0.995**
245 R    0.967*
320 A    0.875
546 A    0.824
M8a (beta&= fixed) 3 -6437.809177 p0=0.995p=0.171
q=0.615
(p1=0.005)( =1)
Not allowed
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Hemagglutinin (HA) New Zealand
      The alternate models M2a orM8 did not identify site classes with a ω > 1 for the HA
dataset from New Zealand and log likelihood values for these models were not significantly
larger than null models either (Table 6). The p-values were close to 1 (Table 4). Therefore,
assumptions of the null models M1a, M7, and M8a that there are no positively selected site-
classes could not be rejected for this dataset. BEB analysis did not identify any site that
belongs to positively selected site-classes with posterior probability greater than 95%.
Table 6 New Zealand HA Dataset (270 Sequences) Selection Pressures
p: Number of parameters
Model p Log-
likelihood
Values (lnL)
Estimates
of
Parameters
Positively
Selected Sites (BEB)
(*: P>95%; **: P>99%)
M0 (One-ratio) 1 -5845.193154 =0.283 Not allowed
M1a (NearlyNeutral) 2 -5819.230525 p0= 0.777(p1= 0.222)
0= 0.090( 1=1)
Not allowed
M2a (PositiveSelection) 4 -5819.230525 p0=0.777p1=0.144(p2=0.079)
0=0.090( 1=1)
2=1.000
42 I         0.512
546 A     0.516
M7 (Beta) 2 -5819.592032 p=0.190
q= 0.474
Not allowed
M8 (Beta& ) 4 -5819.239402 p0=0.778(p1=0.222)p=9.94
q=99.0
=1.000
42 I          0.656
108 K  0.576
320 A      0.518
377 T      0.511
443 L      0.565
546 A      0.661
M8a (Beta&= fixed) 3 -5819.239402 p0=0.778(p1=0.222)p=9.94
q=99.0
( =1)
Not allowed
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Hemagglutinin (HA) Australia
         For the HA dataset from Australia, model M2a did not identify site-classes with a ω > 1
and the log likelihood value (lnL) for this model was not significantly larger than the null
model M1a (Table 7). Even though model M8 suggested ω= 1.4 for 5% of site classes, LRT
comparisons with null models M7 and M8a were not statistically significant to support
positive selection in this dataset (Table 4). BEB analysis did not identify any amino acid sites
that belong to positively selected site-classes with posterior probability greater than 95%.
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Table 7 Australia HA Dataset (107 Sequences) Selection Pressures
p: Number of parameters
Model p Log-
likelihood
Values (lnL)
Estimates of
Parameters
Positively
Selected Sites (BEB)
(*: P>95%; **: P>99%)
M0 (One-ratio) 1 -4360.813739 =0.298 Not allowed
M1a (NearlyNeutral) 2 -4345.410504 p0=0.741(p1=0.259)
0=0.056( 1=1)
Not allowed
M2a (PositiveSelection) 4 -4345.414514 p0=0.741p1=0.163(p2=0.095)
0=0.056( 1=1)
2=1
26 T     0.509
66 G     0.567
204 D    0.569
M7 (Beta) 2 -4345.412883 p=0.089
q=0.209
Not allowed
M8 (Beta& ) 4 -4345.369265 p0=0.953(p1=0.047)p=0.142
q=0.43528
=1.40
7 L       0.634
16 A     0.532
26 T     0.748
66 G     0.820
69 D     0.686
122 A    0.549
128 V    0.522
161 N    0.676
171 T    0.554
204 D    0.822
209 F    0.502
291 G    0.521
320 A    0.551
492 A    0.549
546 A    0.530
M8a (Beta&= fixed) 3 -4345.391964 p0=0.762(p1=0.238)p=0.227
q=2.460
( =1)
Not allowed
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Neuraminidase (NA) USA
      Alternate models M2a orM8 did not identify site-classes with a ω > 1 for the NA dataset
from USA and log likelihood values for these models were not significantly larger than null
models (Table 4, 8). Therefore, the null hypothesis that there are no positively selected site-
classes could not be rejected for this dataset. BEB analysis did not identify any site that
belongs to positively selected site-classes with posterior probability greater than 95%.
Table 8 USA NA Dataset (166 Sequences) Selection Pressures
p: Number of parameters
Model p Log-
likelihood
Values (lnL)
Estimates
of
Parameters
Positively
Selected Sites (BEB)
(*: P>95%; **: P>99%)
M0 (One-ratio) 1 -5082.261559 =0.224 Not allowed
M1a (NearlyNeutral) 2 -5063.991242 p0= 0.846(p1= 0.154)
0= 0.100( 1=1)
Not allowed
M2a(PositiveSelection) 4 -5063.029728 p0=0.847p1=0.103(p2=0.050)
0=0.100( 1=1)
2=1.000
199 K      0.593
221 K      0.689
267 T      0.629
310 Y      0.554
332 S      0.599
386 P      0.586
M7 (Beta) 2 -5062.426558 p=0.280
q= 0.954
Not allowed
M8 (Beta& ) 4 -5062.412581 p0=0.954(p1=0.046)p=0.332
q=1.393
=1.000
199 K      0.632
221 K      0.784
267 T      0.686
310 Y      0.573
332 S      0.634
386 P      0.617
M8a (Beta&= fixed) 3 -5062.409981 p0=0.954(p1=0.0456)p=0.332
q=1.393
=1.000
Not allowed
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Neuraminidase (NA) New Zealand
        Model M2a suggested that 1.7% of sites are under positive selection with ω = 2.62
(Table 9). When models M1a and M2a were compared, the LRT statistic (2  = 2 x -
4523.640514) – -4525.344083)) was 3.4 with p-value 0.18 for df = 2 (Table 4). Since the p-
value was greater than 0.05, the assumption of the null model M1a that there are no positively
selected site-classes in New Zealand NA dataset could not be rejected. For M2a, Bayes
Empirical Bayes (BEB) analysis did not identify any amino acid sites as positively selected
with posterior probability greater than 95% (only 90.4% for 221 K Table 9). However, model
M8 suggested 3% of site-classes with ω = 2.29. When the models M7 and M8 were
compared, p-value was 0.028 for LRS = 7.15 with df = 2 (Table 4). Therefore, the assumption
of model M8 that there are site-classes with positive selection was favored over the
assumption of model M7 that there are no such site-classes. For the M8a and M8 comparison,
LRT statistic was 7.15 with df = 1 (Table 4). The test static for null distribution was greater
than the critical value 2.71 and χ2 distribution had p-value < 0.05. Thus, model M8 was
favored over the null model M8a and the test of positive selection becomes significant. For
M8, Bayes Empirical Bayes (BEB) analysis identified amino acid site 221 K as positively
selected with posterior probability 95.3% (Table 9).
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Table 9 New Zealand NA Dataset (371 Sequences) Selection Pressures
p: Number of parameters
Model p Log-
likelihood
Values (lnL)
Estimates of
Parameters
Positively
  Selected Sites (BEB)
(*: P>95%; **: P>99%)
M0 (One-ratio) 1 -4542.831855 = 0.265 Not allowed
M1a (NearlyNeutral) 2 -4525.344083 p0= 0.855(p1= 0.145)
0= 0.130( 1=1)
Not allowed
M2a (PositiveSelection) 4 -4523.640514 p0=0.893p1=0.090(p2=0.017)
0=0.154( 1=1)
2=2.62
30 A      0.793
40 H      0.630
81 L      0.528
221 K     0.904
267 T     0.517
303 V     0.713
416 S     0.538
434 T     0.526
M7 (Beta) 2 -4527.173151 p=0.288
q=  0.800
      Not allowed
M8 (Beta& ) 4 -4523.596864 p0=0.969(p1=0.031)p=1.01
q= 3.77
=2.29
30 A      0.853
 40 H      0.622
   221 K    0.955*
 303 V     0.749
416 S     0.521
434 T     0.508
M8a (Beta&= fixed) 3 -4525.365320 p0=0.856(p1=0.143)p=14.97
q=99.00
=1.00
Not allowed
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Neuraminidase (NA) Australia
      Alternate models M2a orM8 did not identify site-classes with ω > 1 for NA dataset from
Australia and log likelihood values for these models were not significantly larger than the null
models (Table 10). P-values for LRS were close to 1. Therefore, the null hypothesis that there
are no positively selected site-classes in this dataset could not be rejected.  Agreeing with
these results, BEB analysis did not identify any site that belongs to positively selected site-
classes with posterior probability greater than 95% for either M2a or M8.
Table 10 Australia NA Dataset (79 Sequences) Selection Pressures
p: Number of parameters
Model p Log-
likelihood
Values (lnL)
Estimates of
Parameters
Positively
  Selected Sites (BEB)
(*: P>95%; **: P>99%)
M0 (One-ratio) 1 -3715.823125 = 0.254 Not allowed
M1a (NearlyNeutral) 2 -3711.404483 p0= 0.852(p1= 0.148)
0= 0.136( 1=1)
Not allowed
M2a (PositiveSelection) 4 -3711.404483 p0=0.852p1=0.015(p2=0.133)
0=0.136( 1 =1)
2=1.000
        199 K      0.501
        221 K      0.504
M7 (Beta) 3 -3710.902568 p=0.402
q= 1.165
Not allowed
M8 (Beta& ) 5 -3710.902580 p0=0.99999(p1=0.00001)p=0.402
q=1.165
=1.000
        199 K      0.539
        221 K      0.542
        392 I        0.519
M8a (Beta&= fixed) 3 -3710.902580 p0=0.99999(p1=0.00001)p=0.402
q=1.165
=1.000
Not allowed
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Comparative Selection Pressure Analyses
             To examine whether there is evidence for differential selective pressures between
human influenza A/H3N2 viruses from different geographical locations, datasets from
Australia, New Zealand, and USA were compared pair-wise with each other under branch and
branch-site models for both HA and NA coding regions and the likelihood ratio values (lnL)
and estimates of parameters returned from different models in the CODEML were used to test
different assumptions. Each pair was first tested by branch test by asking whether model M2
in which the population of interest (foreground branch) allowed to have different ω ratio than
another geographical population (background branch) was a better fit into the data than model
M0 with single ω ratio for both populations. Since branch specific models can detect positive
selection only if the average dN over all sites is higher than the average dS for that lineage,
positive selection acting only on a few sites may not be detected by branch models. Therefore,
branch-site tests were conducted to examine whether positive selection might be occurring at
a subset of sites of one population compared to a different population by comparing model A
with model M1a of site-specific model (test 1) and model A with model A null (test 2), where
model A is the alternate model and model M1a and model A null are null models.
Hemagglutinin (HA) Coding Region
           For any pair-wise comparison of  the USA, Australia, and New Zealand HA coding
sequences, model M2 of branch model did not return ω > 1 for foreground branches and the
p-value of likelihood ratio statistic for comparison with model M0 was greater than 0.05
(Table 11). Therefore, it could be inferred that the branch model that allow two different ω
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ratios for the two populations did not fit into the data better than the model with single ω ratio
for both populations for the HA coding region.
Table 11 Comparative selection pressure analyses of HA coding region
Log-likelihood ratio statistics (LRS), degrees of freedom (df), and p-values (P)
The branch-site tests returned site-classes on the foreground branches with ω > 1 for some
pair-wise comparisons (Table 12). When USA coding sequences were treated as the
foreground branches and compared with Australia coding sequences, model A identified two
site-classes (0.24%) with ω = 12.86 (Table 12). To test the statistical significance, this model
was compared with null models that assume no site-classes with ω > 1. The LRS for model A
comparison with site-specific model M1a (test 1) was 11.1 with P=0.004 and the LRS for
model A comparison with model A null (test 2) was also 11.1 with P=0.009 (Table 11). Since
p-values were less then 0.05 null models were rejected in favor of the alternate models with
strong statistical significance.
Branch test HA       Branch-site test HADatasets
                           Model M0
                               Vs.
                           Model M2
                            (df=1)
M1a
        Vs.
    Model A
      (df=2)
Model A Null
  Vs.
    Model A
      (df=1)
Foreground Background LRS P ω0 ωf ωb LRS P LRS P
USA Australia 0.30 0.58 0.28 0.26 0.29 11.1 0.004 11.1 0.0009
USA New Zealand 0.38 0.54 0.29 0.26 0.29 13.4 0.001 13.4 0.0003
New Zealand USA 0.33 0.33 0.29 0.32 0.25 2.29 0.32 0.41 0.52
New Zealand Australia 0.16 0.68 0.29 0.31 0.28 0.52 0.77 0.48 0.49
Australia New Zealand 0.15 0.68 0.29 0.27 0.30 0.48 0.79 0 1
Australia USA 0.38 0.54 0.28 0.30 0.26 0.14 0.93 0 1
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Table 12 Comparative selection pressure analyses of HA coding sequences
                                   Parameter estimates for branch-site model A
     ωb =ω for background branches, ωf= ω for foreground branches, p=proportion
The significance of test 1 indicates that a subset of sites on the population of interest have a
significantly elevated ω ratio compared to those sites on a different population, which in this
case means either significant positive selection or relaxation of selective constraint in the
USA coding region compared to that of Australia. Since test 2 is the direct test of positive
          Branch-site Model A HAForeground Background
Site-Class p ωb ωf
Positive
Sites for
Foreground
Branches
(BEB)
0 0.7846 0.0664 0.0664
1 0.2130 1.0000 1.0000
2a 0.0019 0.0664 12.859
USA Australia
2b 0.0005 1.0000 12.859
65 G   0.684
236 R 0.847
0 0.8065 0.0882 0.0882
1 0.1912 1.0000 1.0000
2a 0.0019 0.0882 12.336
USA New Zealand
2b 0.0005 1.0000 12.336
65 G   0.696
236 R 0.963
0 0.7904 0.0799 0.0799
1 0.1641 1.0000 1.0000
2a 0.0377 0.0799 1.9019
New Zealand USA
2b 0.0078 1.0000 1.9019
21 G  0.690
49 Q  0.513
204 D 0.541
215 S 0.518
289 P 0.517
0 0.7709 0.0653 0.0652
1 0.2238 1.0000 1.0000
2a 0.0041 0.0653 4.9099
New Zealand Australia
2b 0.0012 1.0000 4.9099
21 G 0.614
0 0.7709 0.0578 0.0578
1 0.2060 1.0000 1.0000
2a 0.0183 0.0578 1.0000
Australia New Zealand
2b 0.0049 1.0000 1.0000
None
0 0.7328 0.0519 0.0519
1 0.2180 1.0000 1.0000
2a 0.0379 0.0519 1.0000
Australia USA
2b 0.0113 1.0000 1.0000
None
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selection, its significance means there is enough evidence for the existence of site-classes with
positive selection pressures within the USA coding region compared to that of Australia.
However, the BEB analysis could not identify any amino acid site that could potentially
belong to positively selected site-classes with greater than 95% posterior probability (highest
only 85% for 236 R Table 12). When USA coding region was tested against New Zealand
coding region, model A identified two site-classes (0.24%) with ω = 12.33 (Table 12). LRS
for test 1 was 13.4 with p-value 0.004 and LRS for test 2 was 13.4 with p-value 0.003 (Table
12). Since the p-values were less than 0.05, null models were rejected in favor the alternate
models and it could be inferred that there is enough evidence for the existence of site-classes
with significant positive selection pressures within the USA HA coding region compared to
the New Zealand HA coding region. BEB analysis identified amino acid site 236 R as belongs
to such positively selected site-classes with 96.2% posterior probability (Table 12).
      For comparative selection pressure analysis of the New Zealand HA coding region, model
A identified site-classes with ω = 1.9 for comparison against the USA HA coding region and
site-classes with ω = 4.9 for that against the Australia HA coding region (Table 12). However,
p-values were greater than 0.05 for both test 1 and test 2 (Table 11).  Thus, there was no
statistically significant evidence to support the assumption that there are site-classes with
positive selection pressures on the New Zealand HA coding region compared to the USA or
Australia HA coding region. BEB analysis could not identify any amino acids site that
belongs to positively selected site-classes with greater than 95% probability (Table 12).
       For the Australia HA coding region, model A could not identify site-classes with ω > 1
for comparisons with either the USA or New Zealand HA coding region (Table 12) and log-
likelihood values for this model were not significantly better than the null models (Table 11).
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Thus, the assumption that there are no positively selected site-classes on the Australia HA
coding region in comparison with either the USA or New Zealand HA coding region could
not be rejected. BEB analysis could not identify any amino acid site that belongs to positively
selected site-classes with greater than 50% posterior probability as expected (Table 12).
Neuraminidase (NA) Coding Region
        Like HA datasets, each of the NA datasets from Australia, New Zealand, and USA was
compared pair-wisely with the each other under branch and branch-site models. For branch
test, p-value for the LRS comparing the models M0 and M2 was greater than 0.05 for each
pair-wise comparison (Table 13). Therefore, allowing different ω ratios for the two
populations did not fit into the data better than single ω ratio for two populations for any pair-
wise comparison of NA coding region.
Table 13 Comparative selection pressure analyses of NA coding region
Log-likelihood ratio statistics (LRS), degrees of freedom (df), and p-values
Branch tests NA             Branch-site NA
Model M0
Vs.
Model M2
(df=1)
M1a
     Vs.
 Model A
   (df=2)
Model A Null
Vs.
Model A
      (df=1)
Foreground Background LRS P ω0 ωf ωb LRS P LRS P
USA Australia 0.66 0.42 0.25 0.23 0.27 0 1 0 1
USA New Zealand 0.27 0.64 0.22 0.20 0.23 0 1 0 1
New Zealand USA 2.0 0.16 0.22 0.32 0.25 0 1 1.00 0.32
New Zealand Australia 0.89 0.35 0.26 0.22 0.28 0 1 0 1
Australia New Zealand 2.15 0.14 0.26 0.32 0.22 1.87 0.39 0 1
Australia USA 0.98 0.32 0.25 0.29 0.23 0.44 0.80 0 1
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For branch-site analyses, model A could not identify site-classes with ω > 1 for any pairs
(Table 14). The p-values for test 1 and test 2 of branch-site model were greater than 0.05 for
all pair-wise comparisons (Table 13). Therefore, the assumptions of the null models that there
are no site-classes with positive selection within the NA coding region of one dataset when
compared to the other could not be rejected. Thus, it was inferred that there was not enough
evidence for differential selective pressures acting within the NA coding region of the USA,
New Zealand, and Australia datasets.
Table 14 Comparative selection pressure analyses of NA coding region
Parameter estimates for branch-site model A
     ωb =ω for background branches, ωf= ω for foreground branches, p=proportion
   Branch-site Model A NAForeground Background
Site-Class p ω b ω f
Positive Sites
For Foreground
Branches (BEB)
0 0.8374 0.1069 0.1069
1 0.1627 1.0000 1.0000
2a 0.0000 0.1069 1.0000
USA Australia
2b 0.0000 1.0000 1.0000
None
0 0.8994 0.1006 0.1006
1 0.1006 1.0000 1.0000
2a 0.0000 0.1213 1.0000
USA New Zealand
2b 0.0000 1.0000 1.0000
None
0 0.8994 0.1213 0.1213
1 0.1006 1.0000 1.0000
2a 0.0000 0.1213 1.0000
New Zealand USA
2b 0.0000 1.0000 1.0000
267 T 0.531
0 0.7908
7
0.0707 0.0707
1 0.2091 1.0000 1.0000
2a 0.0000 0.0707 1.0000
New Zealand Australia
2b 0.0000 1.0000 1.0000
None
0 0.7210 0.0459 0.0459
1 0.1006 1.0000 1.0000
2a 0.0842 0.0459 1.0000
Australia New Zealand
2b 0.0204 1.0000 1.0000
None
0 0.8040 0.0981 0.0981
1 0.1513 1.0000 1.0000
2a 0.0376 0.0981 1.0000
Australia USA
2b 0.0071 1.0000 1.0000
None
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Discussion
RIT Influenza Virus Database
      The RIT Influenza Virus Database has many features that would be useful for researchers
interested in genomic data of influenza viruses. The keyword search feature is helpful to
search for specific viruses more quickly, while the advanced search feature is useful to
identify viruses of interest by narrowing down the search criteria. Display options can be used
to retrieve one or more fields for isolates of interest. One feature unique to this database is the
links to complete genome files in FASTA format and to the NCBI resources such as Genbank,
Trace Archive, and Taxonomy for each influenza A virus isolate in the database. Genbank
link navigates to all available Genbank sequences for a particular isolate while Fasta link
provides complete genome sequences. Taxonomy links to the Taxonomy Browser and Trace
links to the Trace Archive at the NCBI. Thus, in the RIT Influenza Virus Database researchers
could download sequences of one or more segments for virus of interest from the database or
from the links to complete genome sequence files or Genbank for that isolate. XML download
format of metadata is another interesting feature on this database. In addition, metadata can
also be downloaded in Tab-delimited and Excel formats to get information about isolates.
       The main advantage of the database design is the separation of different layers. Since
database creation was separated from data retrieval and display, tables in the database can be
updated without changing the interface. Separation of the interface from the database
increases the security as well. Data integrity is maintained by checking user input values for
SQL injections. The design makes it easy to extend the application for future development as
well. The keyword search feature and the advanced search features for search, display, and
sort are easily visible on the interface of the database. The data retrieved by user query are
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first stored as XML before being transformed into HTML for display. An advantage of this
method is that XML in combination with XSLT make it possible to define the content of the
document separately from its formatting. Therefore, the content could be reused for other
purpose such as for downloading, or for transforming into other formats.
      The main disadvantage of the database schema is the existence of two different tables for
A and B viruses. If the data available at the JCVI website were in one format, a single table
could have been created for both A and B viruses which would have made the coding more
easy. Coding complexity also increased due to data being saved as XML before being
transformed into HTML. Limitations of this database are the lack of protein and coding region
sequences for all isolates, and the non-availability of links to the NCBI resources and to the
complete genome assembly files for influenza B viruses. However, once these data are
available at the JCVI website, it could be added to the database without dramatically changing
the interface.
Selection Pressure Analyses
       Selection pressure analyses have been used to predict emerging influenza virus strains
that could cause epidemics or to look for evidence for positive selection at codon sites that
lead to drug resistance or immunity against host. Although, lots of researches have been
focusing on these areas, little is known about whether influenza viruses are under selective
pressures in response to geographical factors. A common method to examine whether a
protein-coding gene has evolved under different selective pressures is by estimating the ratio
of nonsynonymous and synonymous substitution (omega ω) rates at codon sites. We
employed such analyses within coding regions of human influenza A/H3N2 virus datasets
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from different geographical locations, individually as well as pair-wise, to examine whether
evidence of positive selection exists in those populations, and to identify potential amino acid
sites that are under positive selection if positive selection is detected. Even though tropical
regions show year around influenza activity, enough data was not available from those
countries for analyses. Influenza A/H3N2 virus isolates from USA (mainly New York State),
New Zealand, and Australia collected during the period 2001 to 2005 were used for selection
pressure analyses on HA and NA coding regions. The USA dataset represents temperate
regions of Northern hemisphere and Australia and New Zealand datasets represent that of
Southern hemisphere where winter epidemics of influenza are common.
      When individual HA datasets were tested for potential positive selection pressures acting
within them by comparing three pairs of site-specific models in the CODEML, statistically
significant positive selection was detected in the USA dataset by all three comparisons with p-
value < 0.05. BEB analysis by model M2a detected sites 236(R) and 242(V) as positively
selected with greater than 95% posterior probability while model M8 identified one more site,
245 (R). Even though site 245 (R) is identified only by model M8 its significance cannot be
underestimated because of the statistical significance of the direct test of direct positive
selection (M8a vs. M8). Meanwhile, none of the three tests for selection pressures provided
statistical significant evidence to support positive selection within the Australia or New
Zealand HA datasets. Results of the comparative selection pressures analyses agree with these
results. When the USA HA sequences were treated as the foreground branches and compared
pair-wise with each of the Australia and New Zealand sequences by two branch-site tests,
both test 1 and test 2 returned evidence of differential positive selection in the USA coding
sequences with great statistical significance. BEB analysis of model A identified site 236 R as
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positively selected in the USA coding region compared to that of New Zealand with greater
than 95% posterior probability. It is to be noted that site 236 R was also identified as
positively selected in individual analysis of the USA HA coding region. Even though there
was strong evidence of positive selection in the USA coding region compared to that of
Australia, BEB analysis could not identify any amino acid site as positively selected with
greater than 95% posterior probability. The highest posterior probability was for 236 R (85%).
This can be explained based on the observations of Zhang et al. (2005) on their study to
evaluate the branch-site likelihood method in CODEML for detecting positive selection at the
molecular level. In their simulations, it was not uncommon for the BEB method to not
identify any site as positively selected with greater than 95% posterior probability even
though branch-site tests for positive selection significantly supported positive selection on the
foreground branches. According to the authors, identifying sites under positive selection is a
more difficult task than testing whether such sites exist because information from any single
site with ω > 1 may not be strong enough for the BEB probability to reach high levels. They
suggest that, even if sites with positive selection cannot be inferred, significance of positive
selection acting within the sequences is reliable. Therefore, even if no sites are identified as
positively selected for the USA HA coding region in comparison with Australia, the evidence
of positive selection in the USA coding region compared to that of Australia could be
considered significant. The three sites identified as positively selected by individual dataset
analyses and the one site identified by comparative analyses of the USA HA dataset were not
identified as positively selected with greater than 50% posterior probability for both Australia
and New Zealand datasets either by individual analyses or by comparative analyses. From the
results of our analyses it can be inferred that geographically distinct positive selection
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pressures act within the HA coding region of influenza A/H3N2 viruses from the USA. Even
though amino acid sites 242(V) and 245 (R) were identified as positively selected by
individual analyses of the USA dataset, positive selection was not detected for those sites by
comparative analyses with greater than 50% posterior probability. This may be due to the
smaller number of sequences taken for comparative analyses compared to individual dataset
analyses.
           When individual NA datasets were tested for potential positive selection pressures
acting within them by comparing three pairs of site-specific models, statistically significant
positive selection was detected in the New Zealand dataset by M7 vs. M8 and M8a vs. M8
with P < 0.05 while M1a vs. M2a did not detect positive selection with statistical significance.
One site, 221 K was identified as positively selected with greater than 95% posterior
probability by model M8, but not by model M2a. The comparison M1a vs. M2a could not
detect evidence for positive selection, may be because positive selection was acting on just
one site. Model M2a divides the aligned sequences into 3 site-classes compared to 11 site-
classes in M8 and thus, more codons are placed on the site-class with ω > 1 by model M2a.
When there are multiple sites with ω > 1, the LRT combining information from all such sites
may be able to detect positive selection, while information from any single site with ω > 1
may be masked by the other sites placed on the same site-class (Zhang et al. 2005). Since the
other two tests are significant, it can be inferred that there is enough evidence to support
positive selection acting on the New Zealand NA coding region. For analyses of the USA and
Australia NA datasets individually, all three pairs of site-specific model comparisons were not
statistically significant to support positive selection acting within them. For comparative
analyses of the NA coding region, all pair-wise comparisons between USA, Australia, and
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New Zealand returned no statistically significant evidence for differential selection pressures
acting between them. Individual dataset analyses indentified site 221 K as positively selected
in the New Zealand NA dataset, but comparative analyses could not identify differential
positive selection at that site. Even though not statistically significant, this site was identified
as positively selected with greater than 50% posterior probability for both USA and Australia
coding regions by individual analyses. This may be one of the reasons that the site was not
identified as differentially selected for New Zealand by comparative selection pressure
analyses. Other reason can be relatively smaller sample size taken for comparative analyses.
From the results of individual and comparative analyses of NA coding region, we can infer
that there is evidence to support existence of positive selection pressures in New Zealand NA
coding region, but chances are that it is a weaker positive selection. However, there was not
enough evidence to support differential positive selection pressures in NA coding region for
any of the three geographical populations.
      Five epitope regions have been identified previously in H3N2 for HA1 domain (Lees et al.
2010). Although early models proposed that a strain has to develop at least one mutation in
each of these five antibody-combining sites for antibody escape, recent focus is on
immunodominant amino acid locations (Lees et al. 2010). Lees et al. (2010) suggests that
locations where selection pressures act and the significance of specific locations that
determine the strength of immune response can change over time. They proposed additional
assignments of amino acid residues to be part of these five epitopes based on computational
analyses. Table 15 lists the previously assigned and proposed sites. Three epitope regions
have been identified previously in H3N2 for N2 domain of NA protein: A (16 residues 383-
387, 389-394, 396, 399, 400, 401, 403), B (6 residues 197-200, 221, 222), C (23 residues 328-
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332, 334, 336, 338, 339, 341-344, 346, 347, 357-359, 366-370) (Munoz & Deem 2004). It has
been shown that single amino acid site change at positions 198, 199, 220, or 221 of NA
protein was sufficient to effectively abolish antibody binding (Gulati et al. 2002).
Table 15 Assignment of amino acid residues of H3N2 HA1 domain to five epitopes
       In our analyses we included whole coding regions, and so, the HA1 domain starts from
the 17th codon position. It is clear from our results that, the sites that are identified as under
positive selection pressures in our analyses are parts of these known or proposed epitopes or
antibody-combining sites. The sites 236[220], 242[226], and 245 [229] of HA protein that are
identified as positively selected are in epitope D and the site 221 of NA protein that is
identified as positively selected is in epitope B. Munoz & Deem (2004) suggests that changes
in the epitopes are favored by natural selection and positive selection at or near epitope
regions allow the viruses to evolve against antibody activity to evade adaptive response of
host immune system. Since point mutations at the amino acid sites in the epitope regions not
Epitope Previously identified residues Proposed additional assignments
A 122, 124, 126, 130–133, 135, 137,
138, 140, 142–146, 150, 152, 168 (n =
19)
71–72, 98, 127, 141, 148–149, 151, 255 (n
= 28)
B 128, 129, 155–160, 163–165, 186–
190, 192–194, 196–198 (n = 22)
161–162, 199 (n = 25)
C 44–48, 50, 51, 53, 54, 273, 275, 276,
278–280, 294, 297, 299, 300, 304,
305, 307–312 (n = 27)
41–43, 49, 52, 55, 271–272, 274, 282,
284–285, 287–293, 295–296, 298, 301–
303, 313–314 (n = 54)
D 96, 102, 103, 117, 121, 167, 170–177,
179, 182, 201, 203, 207–209, 212–
219, 226–230, 238, 240, 242, 244,
246–248 (n = 41)
95, 97, 99–101, 104–105, 107, 118, 120,
166, 169, 178, 180, 183–184, 200, 204–
206, 210–211, 220–225, 231–236, 239,
243, 245, 257–258 (n = 80)
E 57, 59, 62, 63, 67, 75, 78, 80–83, 86–
88, 91, 92, 94, 109, 260–262, 265 (n =
22)
56, 58, 60, 64–65, 68–70, 73–74, 76–77,
79, 84–85, 89–90, 93, 110–115, 119, 259,
263–264, 267–270 (n = 54)
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recognized by antibodies circulating in the existing population, these changes can reduce the
immune response considerably (Munoz & Deem 2004).
      The importance of our study is that the positive selection at epitope regions is evident
only in distinct geographical populations, USA for HA coding region and New Zealand for
NA coding region. Our results do not agree with the results of phylogenetic analyses by
Nelson et al. in (2006, 2007) and Rambaut et al. (2008) that influenza viruses do not regularly
evolve in geographic isolation, instead evolution is influenced by frequent cross-hemisphere
migration or evolution within and migration from the tropical source population. If viruses
evolved elsewhere and migrated to these temperate regions instead of undergoing local
adaptive evolution, influenza viruses from both hemispheres should have shown evidence for
similar selection pressures or no selection pressures at all on individual analyses, and no
evidence for differential positive selection pressures on comparative analyses. Instead, only
viruses from the USA returned strong evidence for positive selection as well as differential
positive selection for HA coding region and only isolates from New Zealand showed evidence
of positive selection, though weak, for NA coding region. From the results of our analyses, we
speculate that even though there may be adaptive evolution due to migration, geographically
distinct human influenza A/H3N2 viruses still undergo adaptive evolution in response to
factors that are local, to evade existing immunity in the host population through mutations in
the antibody-combining sites. To capture these intrinsic processes happening at molecular
level phylogenetic analysis alone may not be sufficient, but need codon level analysis.
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Conclusion
     The RIT Influenza Virus Database is a web-based program for researchers to query for
influenza A and B virus isolates of interest to obtain complete genome sequences for both A
and B viruses from the database or from the corresponding resources in Genbank for
influenza A virus isolates. In addition, metadata of the isolates can be easily viewed and
downloaded in different format from this resource.
     Analyses of positive selection pressures acting on geographically distinct human influenza
A/H3N2 virus isolates, by estimating nonsynonymous/synonymous substitution rate ratio at
codon sites using codon-based maximum likelihood methods, have returned evidence of
strong positive selection as well as differential positive selection acting within hemagglutinin
(HA) coding regions of isolates from the USA and evidence of weak positive selection acting
within neuraminidase (NA) coding region of isolates from New Zealand, at epitope regions.
From the results, we can speculate that even though there is adaptive evolution due to global
migration, geographically distinct human influenza A/H3N2 virus populations still undergo
adaptive evolution in response to local factors through mutations in antibody-combining sites
to evade existing immunity in the host population. Further research is needed to confirm our
findings.
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